This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
T-cell Prolymphocytic Leukemia
Information about T-cell Prolymphocytic Leukemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of T-cell Prolymphocytic Leukemia
Most recent studies have shown that T-cell Prolymphocytic Leukemia shares some biological mechanisms with acute-lymphocytic-leukemia, adult-t-cell-lymphoma-leukemia, ataxia-telangiectasia, chronic-lymphocytic-leukemia, cytogenetic-abnormality, htlv-i-infections, leukemia, leukemia-t-cell, leukemia-t-cell-chronic, lymphocytosis, lymphoid-leukemia, lymphoma, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, prolymphocytic-leukemia, t-cell-large-granular-lymphocyte-leukemia, t-cell-lymphoma.
Among the many pathways, these few ones have gauged particular interests from scientists studying T-cell Prolymphocytic Leukemia, and have been seen in publications frequently: Antibody-dependent Cellular Cytotoxicity, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Dna Hypermethylation, Dna Integration, Dna Methylation, Killer Activity, Leukocyte Migration, Localization, Methylation, Pathogenesis, Programmed Cell Death, Reverse Transcription, Translation, Transport, Tropism, V(d)j Recombination
Quite a number of genes have been found to play important roles in T-cell Prolymphocytic Leukemia, such as AKT1, ATM, CD2, CD4, CD5, CD52, CD7, CD8A, CTLA4, HLA-DQA1, IL2, INVS, LMLN, MTCP1, NOD2, SH2D1A, TCL1A, TCL1B. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.